Biomarker Research in Musculoskeleton Disease

$182,292K24FY2012ARNIH

University Of California, San Francisco, San Francisco CA

Investigators

Linked publications & trials

Paper 31294761 Paper 29318649 Paper 29158435 Paper 29140951 Paper 29061566 Paper 29034571 Paper 28976862 Paper 28965356 Paper 28850708 Paper 28781992 Paper 28731209 Paper 28648751 Paper 28590522 Paper 28583247 Paper 28577798 Paper 28482002 Paper 28475634 Paper 28409686 Paper 28402245 Paper 28316103 Paper 28232047 Paper 28112618 Paper 28083880 Paper 27689250 Paper 27603906 Paper 27027655 Paper 26905017 Paper 26728471 Paper 26724528 Paper 26495751 Paper 26458388 Paper 26305617 Paper 26265732 Paper 26228936 Paper 26202797 Paper 26104910 Paper 26010634 Paper 25893284 Paper 25856213 Paper 25642590 Paper 25294595 Paper 25284702 Paper 25127011 Paper 25111880 Paper 25089863 Paper 25027581 Paper 24915118 Paper 24890537 Paper 24798675 Paper 24760077 Paper 24449050 Paper 24213602 Paper 24131178 Paper 24093862 Paper 23983224 Paper 23941540 Paper 23633199 Paper 23408577 Paper 23322676 Paper 23291338 Paper 23222000 Paper 23144985 Paper 23018684 Paper 22879205 Paper 22877810 Paper 22821943 Paper 22818906 Paper 22797491 Paper 22732750 Paper 22723583 Paper 22648990 Paper 22573914 Paper 22571169 Paper 22546961 Paper 22532515 Paper 22529182 Paper 22516286 Paper 22496264 Paper 22470551 Paper 22442276 Paper 22392817 Paper 22387199 Paper 22286411 Paper 22238396 Paper 22228250 Paper 22187968 Paper 22092102 Paper 22080379 Paper 22072593 Paper 22005919 Paper 21956772 Paper 21949033 Paper 21802828 Paper 21724748 Paper 21710615 Paper 21710614 Paper 21668915 Paper 21632482 Paper 21625880 Paper 21605729

Abstract

DESCRIPTION (provided by applicant): Osteoporosis is a significant concern for both older men and women. Recent studies suggest skeletal biomarkers might provide important information about the biologic causes of osteoporosis and may be useful to predict fracture alone or when combined with other risk factors. To extend his ongoing NIH-funded work on biomarkers and skeletal fragility, Dr. Douglas Bauer, Professor of Medicine, Epidemiology & Biostatistics at the University of California, San Francisco, is requesting a renewal of his K24 Midcareer Investigator Award in Patient-Oriented Research with the scientific goals of developing new and clinically useful proteomic biomarkers using data from a well characterized longitudinal cohort of older men (MrOS). Taking advantage of ongoing assessments for fracture and recent funding for proteomic measurements in serum collected at baseline, this study will explore the prospective relationship between proteomic profile and incident vertebral fracture in 3000 MrOS participants. Using these and other data from multiple large studies available through his longstanding affiliation with the San Francisco Coordinating Center, Dr. Bauer will continue to mentor young investigators who are interested in clinical research, particularly residents. With the initial K24 award Dr. Bauer mentored residents and fellows who are now pursuing additional research training and academic careers. In conjunction with the UCSF Clinical and Translational Science Institute, during the initial K24 award he also developed and directed a new comprehensive Resident Research Program. The goal of this novel program is to promote clinical research careers by providing residents with formal instruction in research methods, pilot funding and opportunities to participate in mentored research projects. The continuation of this K24 award is critical to protect Dr. Bauer's time and allow him to continue to make significant contributions towards patient-oriented research related to biomarkers and skeletal fragility and to expand his successful mentoring program.

View original record on NIH RePORTER →